Suppr超能文献

印度南部一家三级护理医院中按照 SIOP WT 2001 方案治疗的 Wilms 瘤患儿的临床结局。

Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.

机构信息

Department of Paediatric Oncology, Christian Medical College, Vellore, India.

Department of Paediatric Surgery, Christian Medical College, Vellore, India.

出版信息

J Pediatr Urol. 2018 Dec;14(6):547.e1-547.e7. doi: 10.1016/j.jpurol.2018.05.020. Epub 2018 Jun 28.

Abstract

INTRODUCTION

Wilms tumor is the most common pediatric renal malignancy. While developed countries have had excellent survival, it remains poorer by comparison in developing countries. The aim was to analyze the clinical outcome of children with Wilms tumor managed in a developing country from 2004 to 2014 by the SIOP WT 2001 protocol.

METHODS

Fifty-nine children with Wilms tumor managed by a SIOP WT 2001 regimen from 2004 to 2014 were analyzed.

RESULTS

The median age at presentation was 36 months, and 59% were boys. The average size of the tumor at presentation was 523 mL. Inferior vena cava thrombus was present in 11, distant metastases in 18, and bilateral tumors in six. Preoperative chemotherapy was given to all children after a diagnostic core needle biopsy. Preoperative chemotherapy reduced the tumor size to a mean of 208 mL and resolved venacaval thrombus in eight. Fifty-five children underwent definitive surgery while two children died during preoperative chemotherapy and two remained inoperable. All surviving children received adjuvant chemotherapy with 17 receiving radiotherapy as well. The overall survival (OS) was 80% and the event-free survival (EFS) was 73% after a mean follow up of 42 months after completion of therapy.

DISCUSSION

The tumor volumes at presentation and the incidence of venous tumor thrombosis in our cohort were much higher than those reported from developed countries. The incidence of metastatic disease at diagnosis (30.5%) was significantly higher than the 10-12% reported in Western data, but similar to that reported from various developing countries (14.1-31%). The OS in our cohort was 80% and the EFS was 73% with there being no events after 28 months. Although the survival rate for localized disease is similar to that in developed countries, the OS for metastatic disease was significantly less (50% vs. 75%). We also found that using an upfront posterior flank core biopsy was safe and beneficial for differentiating Wilms tumor from other pediatric renal tumors that are less chemosensitive.

CONCLUSION

In a resource-restricted environment such as ours, the SIOP WT 2001 protocol has been found to show excellent results.

摘要

简介

肾母细胞瘤是儿童中最常见的肾恶性肿瘤。虽然发达国家的生存率非常高,但在发展中国家仍然较差。本研究旨在通过 SIOP WT 2001 方案分析 2004 年至 2014 年在发展中国家管理的儿童肾母细胞瘤的临床结果。

方法

分析了 59 例采用 SIOP WT 2001 方案治疗的肾母细胞瘤患儿。

结果

中位发病年龄为 36 个月,59%为男性。就诊时肿瘤平均大小为 523ml。11 例存在下腔静脉血栓,18 例存在远处转移,6 例为双侧肿瘤。所有儿童在诊断性核心针活检后均接受术前化疗。术前化疗使肿瘤大小缩小至平均 208ml,并解决了 8 例下腔静脉血栓。55 例儿童接受了确定性手术,而 2 例儿童在术前化疗期间死亡,2 例儿童仍无法手术。所有存活儿童均接受辅助化疗,其中 17 例接受放疗。在完成治疗后平均随访 42 个月后,总生存率(OS)为 80%,无事件生存率(EFS)为 73%。

讨论

我们队列的肿瘤体积和静脉肿瘤血栓的发生率明显高于发达国家报道的水平。诊断时转移性疾病的发生率(30.5%)明显高于西方数据报道的 10-12%,但与各种发展中国家报道的水平(14.1-31%)相似。我们队列的 OS 为 80%,EFS 为 73%,28 个月后无事件发生。虽然局限性疾病的生存率与发达国家相似,但转移性疾病的 OS 明显较低(50% vs. 75%)。我们还发现,采用 upfront 后外侧入路核心活检是安全且有益的,可以区分对化疗敏感性较低的其他小儿肾肿瘤与 Wilms 肿瘤。

结论

在资源有限的环境中,如我们的环境,SIOP WT 2001 方案已被证明具有优异的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验